Literature DB >> 2123917

Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone.

M C Edelstein1, R G Brzyski, G S Jones, S J Muasher.   

Abstract

There is a subset of patients who fail to respond adequately to exogenous gonadotropin stimulation for in vitro fertilization (IVF). In this study, six such low-responder patients who had inadequate stimulations with high-dose intramuscular (im) follicle stimulating hormone (FSH) were treated in a subsequent cycle with pulsatile intravenous (iv) FSH. A paired analysis was performed to compare the cycles using high-dose im FSH with those using pulsatile iv FSH. Trough serum FSH levels were significantly higher with pulsatile iv FSH. No significant difference was noted in the stimulation characteristics or the number or quality of oocytes retrieved and embryos transferred. No pregnancies occurred in either group. While pulsatile iv administration of gonadotropin increases serum FSH levels, it does not appear to have a major impact on follicular stimulation or outcome in low-responder patients undergoing IVF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123917     DOI: 10.1007/bf01129534

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN: 0740-7769


  17 in total

1.  Stimulation of multiple follicular growth for in vitro fertilization by administration of pulsatile luteinizing hormone-releasing hormone during the midfollicular phase.

Authors:  R W Shaw; G Ndukwe; D Imoedemhe; G Burford; R Chan
Journal:  Fertil Steril       Date:  1986-07       Impact factor: 7.329

2.  Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.

Authors:  Y Nakamura; Y Yoshimura; K Tanabe; R Iizuka
Journal:  Fertil Steril       Date:  1986-07       Impact factor: 7.329

3.  Pulsatile patterns of gonadotropin release in subjects with and without ovarian function.

Authors:  S S Yen; C C Tsai; F Naftolin; G Vandenberg; L Ajabor
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

4.  Pulsatile gonadotropin administration in in-vitro fertilisation.

Authors:  A M Afnan; S G Hillier; R A Margara; S Franks; R M Winston
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

5.  Stimulation protocols for patients with "atypical response".

Authors:  S J Muasher
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

6.  Circhoral oscillations of plasma LH levels in the ovariectomized rhesus monkey.

Authors:  D J Dierschke; A N Bhattacharya; L E Atkinson; E Knobil
Journal:  Endocrinology       Date:  1970-11       Impact factor: 4.736

7.  Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion.

Authors:  N Reame; S E Sauder; R P Kelch; J C Marshall
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

8.  The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.

Authors:  S J Muasher; J E Garcia; Z Rosenwaks
Journal:  Fertil Steril       Date:  1985-07       Impact factor: 7.329

9.  Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization.

Authors:  L L Veeck; J W Wortham; J Witmyer; B A Sandow; A A Acosta; J E Garcia; G S Jones; H W Jones
Journal:  Fertil Steril       Date:  1983-05       Impact factor: 7.329

10.  The use of pure follicle-stimulating hormone for ovulation induction in normal ovulatory women in an in vitro fertilization program.

Authors:  J B Russell; M L Polan; A H DeCherney
Journal:  Fertil Steril       Date:  1986-06       Impact factor: 7.329

View more
  1 in total

1.  Use of granulosa-luteal cell culture to evaluate low and high clinical responses to menotropin stimulation.

Authors:  B S Hurst; H A Zacur; W D Schlaff; G D Berkovitz
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.